Coronavirus 2019 (COVID-19) has created a global pandemic that is devastating human
lives, public healthcare systems, and global economies. Multiple effective and safe COVID …

There are currently eight vaccines against SARS-CoV-2 that have received Emergency Use
Authorization by the WHO that can offer some protection to the world's population during the …

Background Pregnant and lactating women were excluded from initial coronavirus disease
2019 vaccine trials; thus, data to guide vaccine decision making are lacking. Objective This …

Pregnant patients with COVID-19 are more likely to require intensive care and die compared
with noninfected pregnant women. While the consequences of COVID-19 disease in …

Objectives The aim of this study was to assess acceptance of COVID‐19 vaccination and the
willingness to pay (WTP) for it, and investigate associated factors among pregnant women in …

Background Data regarding symptoms in the lactating mother-infant dyad and their immune
response to COVID-19 mRNA vaccination during lactation are needed to inform vaccination …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during
pregnancy and early infancy can result in severe disease. Evaluating the serologic response …

Objective We aimed to assess the impact of early versus late third-trimester maternal severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination on transplacental …

BACKGROUND Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–specific
antibodies have been detected in human milk up to 6 weeks post–coronavirus disease 2019 …

Objective Pregnant patients with COVID-19 are at an increased risk for severe illness when
compared with nonpregnant patients. 1 None of the COVID-19 messenger RNA (mRNA) …